Elran Haber, PhD, MBA
Chief Executive Officer
Dr. Haber serves as Biomica’s Chief Executive Officer. Prior to joining Biomica Dr. Haber served as Therapix Biosciences (Nasdaq, TASE: TRPX) CEO leading the company to a successful IPO on Nasdaq and advancing the Company's programs to clinical stage.
Dr. Haber spent more than 10 years as Chairman and board member of several privately held, and publicly traded companies. Dr. Haber has served in senior executive roles in various life science companies and a private investment firm.
Dr. Haber holds a PhD in Pharmaceutical Science and an MBA in Finance & Financial Engineering, both from The Hebrew University of Jerusalem, Israel